| NDC Code | 75987-130-15 |
|---|
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (75987-130-15) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
|---|
| Product NDC | 75987-130 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Tepezza |
|---|
| Non-Proprietary Name | Teprotumumab |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20200121 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA761143 |
|---|
| Manufacturer | Horizon Therapeutics USA, Inc. |
|---|
| Substance Name | TEPROTUMUMAB |
|---|
| Strength | 500 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC], Insulin-like Growth Factor-1 Receptor Inhibitors [MoA] |
|---|